We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Rapid Mass Spectrometry Technique Identifies Brain Tumors in Situ

By HospiMedica International staff writers
Posted on 20 Feb 2013
A new diagnostic tool could provide near-real time intraoperative molecular diagnosis and margin assessment of brain tumors, according to a new study. More...


Researchers at Purdue University (Purdue, West Lafayette, IN, USA) and Brigham and Women's Hospital (Boston, MA, USA) developed the new tool, which sprays a microscopic stream of charged solvent onto tissue surfaces to gather information on molecular makeup, producing a color-coded image that reveals the nature and concentration of tumor cells. The tool relies on an ambient mass spectrometry analysis technique called desorption electrospray ionization (DESI), which evaluates the distribution and amounts of lipids within the brain tissue.

While conventional mass spectrometry requires chemical separations, manipulations of samples, and containment in a vacuum chamber for ionization and analysis, the DESI technique eliminates these requirements by performing the ionization step directly on surfaces outside of the mass spectrometers. Lipid patterns that correspond to the different types and grades of cancer and concentrations of tumor cells can then be identified using a software program that characterizes the brain tumors, detect boundaries between healthy and cancerous tissue, and displays the results in a color-coded map. The study was published on January 29, 2013, in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).

“We hope to eventually be able to perform this analysis during surgery to help guide brain surgeons so that the borders of tumors can be identified and the cancer status of a site can be established before any tissue is removed,” said lead author Professor of Chemistry R. Graham Cooks, PhD, of Purdue. “We aren't there yet, but this was a critical step in the process. It shows we've found easily identifiable molecular patterns that can be used to diagnose the type and concentration of cancer cells.”

“The new tool is able - in a matter of seconds - to identify and classify glioma and meningioma tumors and recognize the tumor grade,” said study coauthor Sandro Santagata, MD, a pathologist at Brigham and Women's Hospital. “It is able to establish the same type of assessment the pathology offers, but at a pace that is compatible with surgery.”
Pathological examination of specimens taken from the brain during surgery provides the most specific information about the tissue and diagnosis of the cancer. However, this examination of frozen sections takes about half an hour, which is too long for it to be useful in examining multiple samples and guiding surgery.

Related Links:

Purdue University
Brigham and Women's Hospital




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Radiofrequency Generator
GX1
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.